tiprankstipranks
Maze Therapeutics, Inc. (MAZE)
NASDAQ:MAZE
US Market
MAZE
Maze Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see MAZE full AI Analyst Report?

Maze Therapeutics, Inc. (MAZE) Financial Statements

90 Followers

Maze Therapeutics, Inc. Financial Overview

Maze Therapeutics, Inc.'s market cap is currently $1.33B. The company's EPS TTM is $-0.65; its P/E ratio is ―; Maze Therapeutics, Inc. is scheduled to report earnings on April 6, 2026, and the estimated EPS forecast is $-0.57. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 167.50M$ 0.00$ 0.00
Gross Profit$ -2.40M$ 167.50M$ 0.00$ 0.00
Operating Income$ -142.90M$ 57.59M$ -98.55M$ -111.03M
EBITDA$ -140.50M$ 60.88M$ -94.46M$ -107.21M
Net Income$ -131.12M$ 52.23M$ -100.42M$ -114.94M
Balance Sheet
Cash & Short-Term Investments$ 341.92M$ 196.81M$ 29.16M$ 99.92M
Total Assets$ 397.13M$ 240.54M$ 71.50M$ 149.96M
Total Debt$ 23.31M$ 26.63M$ 49.62M$ 32.05M
Net Debt$ -165.94M$ -170.18M$ 20.46M$ -67.86M
Total Liabilities$ 42.16M$ 43.64M$ 61.45M$ 48.51M
Stockholders' Equity$ 354.97M$ 196.90M$ 10.05M$ 101.44M
Cash Flow
Free Cash Flow$ -112.73M$ 74.81M$ -87.27M$ -101.17M
Operating Cash Flow$ -111.94M$ 75.95M$ -86.83M$ -99.20M
Investing Cash Flow$ -170.96M$ -1.15M$ -441.00K$ -3.17M
Financing Cash Flow$ 275.34M$ 92.85M$ 16.39M$ 1.73M
Currency in USD

Maze Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Maze Therapeutics, Inc. Debt to Assets

Balance Sheet >

Maze Therapeutics, Inc. Cash Flow

Cash Flow >

Maze Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >